Welcome to Season 2 of the award-winning Precision Medicine Podcast

Clinical conversations about the effective use of precision medicine for cancer care.


Get the latest episode straight to your in-box.

Archive: Season 1
Breast Cancer Specialist Dr. Mark Moasser Discusses Overcoming Barriers to Clinical Trial Access


Dr. Mark Moasser, a physician-scientist and breast cancer specialist at the University of California, San Francisco discusses his research focus on the HER2 oncogene, the latest trial findings and the importance of improving patient access to clinical trials.  Listen here

Airdate: 09.03.20   |   Length: 24:20

Lori Brisbin Explains How Trapelo Helps Keep Texas Oncology Ahead of the Precision Medicine Curve

Lori Brisbin, Vice President of Precision Medicine at Texas Oncology, shares how this expansive network of oncologists is leveraging the web-based Trapelo™ platform to provide evidence-based decision support to its physicians and bring precision medicine to the forefront of patient care.  Listen here

Airdate: 08.04.20   |   Length: 15:42

Robin Toft on the Life Science Industry’s Talent Crisis, Advancement for Women, and Why It’s Critical for CEO’s to Focus on Diversity

Author and CEO of the Toft Group (a ZRG company), Robin Toft, joins us to discuss her new book, We Can, and share her thoughts on the need for more women and greater diversity in the C-suite and the boardroom within the life science industry.  Listen here

Airdate: 07.01.20   |   Length: 19:24

Dr. Roy Smythe Explains the Importance of Protein Expression in Practicing Precision Medicine

Physician scientist Dr. Roy Symthe discusses how, unlike genes, proteins are always changing and therefore can tell us something new about a patient’s current health state and potentially their future health state. Dr. Smythe is CEO of SomaLogic, a company that scans human proteins to gain insights into the past, current, and future health of patients, making it a promising new technology for precision medicine outcomes.  Listen here

Airdate: 05.28.20   |   Length: 30:11

The ROS1ders: Lung Cancer Patients Turned Precision Medicine Advocates and Superheros

Lung cancer patients Lisa Goldman and Tori Tomalia share their personal stories and motivation to create their organization, the ROS1ders, which advocates and supports those with ROS1-positive cancer— a group that represents just 2% of lung cancer patients.  Listen here

Airdate: 04.29.20   |   Length: 22:59

Dr. John Quackenbush Part 2: Embracing Biological Complexity to Realize the Potential of Precision Medicine

In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations.  Listen here

Airdate: 03.29.20   |   Length: 15:50

The Impact of Precision Medicine on Gastrointestinal Disease

Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, discusses how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away. Listen here

Airdate: 03.04.20   |   Length: 24.53

Precision Medicine is Here: Preparing a New Generation of Scientists to Apply It

Barbara Fortini, PhD, Program Director for the Master of Science in Human Genetics and Genomic Data Analytics at the Keck Graduate Institute shares what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Listen here

Airdate: 02.14.20   |   Length: 30:35

Dr. Adam Brufsky shares findings from the recent San Antonio Breast Cancer Symposium and the important role of precision medicine

In this episode of the Precision Medicine Podcast, Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center shares the newest findings presented in December 2019 at the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Listen here

Airdate: 01.24.20   |   Length: 30:50

Dr. John Quackenbush Part 1: Using Massive Data to Approach Precision Medicine Beyond Simple Mutations

In this first episode of season two, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project.

Listen here

Airdate: 01.09.20   |   Length: 24:10

Archive: Season 1

How can we resolve the complexities of using precision medicine for cancer care?

Trapelo knows.


PHONE  617.250.7572

FAX  888.972.5991

EMAIL info@trapelohealth.com

800 District Ave, Suite 310
Burlington, MA 01803

Google Map »

Copyright 2020 Trapelo Health. All rights reserved. Privacy Policy